【参考文献】
1. Allanore Y, Simms R, Distler O, et al. Systemic sclerosis [J]. Nat Rev Dis Primers, 2015, 1: 15002.
2. Barnes J, Mayes M D. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers [J]. Curr Opin Rheumatol, 2012, 24(2): 165-70.
3. Wynn T A. Fibrotic disease and the T(H)1/T(H)2 paradigm [J]. Nat Rev Immunol, 2004, 4(8): 583-94.
4. Kuzumi A, Yoshizaki A, Matsuda K M, et al. Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis [J]. Nat Commun, 2021, 12(1): 5947.
5. Lee C G, Homer R J, Zhu Z, et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1) [J]. J Exp Med, 2001, 194(6): 809-21.
6. Maresz K, Pryce G, Ponomarev E D, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells [J]. Nat Med, 2007, 13(4): 492-7.
7. Alcigir M E, Dogan H O, Atalay Vural S, et al. Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism [J]. Dev Neurobiol, 2017, 77(11): 1334-47.
8. Palazuelos J, Davoust N, Julien B, et al. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis [J]. J Biol Chem, 2008, 283(19): 13320-9.